Tharimmune raises $5.35 million in registered direct offering

Tharimmune Inc. (NASDAQ: THAR) announced it entered into a securities purchase agreement for a registered direct offering of $5.35 million on August 26, 2025.

The offering consists of 1,188,888 shares of common stock priced at $4.50 per share. The transaction is expected to close on August 27, 2025, subject to customary closing conditions.

The company is conducting the offering under a shelf registration statement on Form S-3 that was filed with the Securities and Exchange Commission and became effective on March 24, 2023. The shares are being offered through a prospectus supplement and accompanying prospectus filed with the SEC.

President Street Global LLC and RF Lafferty & Co. Inc. are serving as exclusive co-placement agents for the offering. Tharimmune agreed to pay the placement agents a cash fee equal to 10% of the aggregate gross proceeds from the sale of securities.

The information is based on the company's press release statement.

You May Also Be Interested In

• Aggreko files for NYSE IPO under ticker AGKO
• SEC Subpoenas Banks For Details On Situational Awareness - NYT
• Sphere 3D shareholders approve name change to DarkHorse Technologies